Incyte Corp (NAS:INCY)
$ 129.93 +0.045 (+0.03%) Market Cap: 25.96 Bil Enterprise Value: 21.98 Bil PE Ratio: 18.35 PB Ratio: 4.62 GF Score: 86/100

Incyte Corp at RBC Capital Markets Global Healthcare Conference Transcript

May 19, 2026 / 02:30PM GMT
Release Date Price: $95.6 (+0.43%)
Brian Abrahams
RBC Capital Markets Inc - Managing Director

Next featured company, Incyte, represented by their Chief Medical Officer, Steven Stein. So thanks so much for joining us, Steven.

Steven Stein
Incyte Corp - Executive Vice President, Chief Medical Officer, Head - Late-stage Development

Thanks for having me. It's good to be here.

Questions & Answers

Brian Abrahams
RBC Capital Markets Inc - Managing Director

So a lot to cover. So -- and I don't want to spend the whole time on 989 because I know you have just a few other things in your pipeline. But I do want to start there just because I know it's a topic of high interest, and there's a lot of recent data and developments of late. Maybe just on the 989 for ET, you guys recently announced Phase 3 plans after speaking with the FDA, and that program is going to start midyear. Can you walk us through some of the unique elements in that design and in particular, the ability to shorten the typical registration requirements and the implications of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot